Literature DB >> 29720433

Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection.

N Jazmati1,2, E Kirpal3, E Piepenbrock3, Y Stelzer3, M J G T Vehreschild2,4, H Seifert3,2.   

Abstract

For the diagnosis of Clostridium difficile infection (CDI), microbiological testing is almost always accomplished through the analysis of stool specimens. We evaluated the performances of rectal swabs with liquid transport medium (FS) and nylon flocked dry swabs for the detection of C. difficile Additionally, the impact on the diagnostic yield of storing swabs at -80°C for up to 3 months was evaluated. Sixty clinical stool samples positive for C. difficile by PCR were used for simulating rectal swabbing. FS and dry swabs were dipped into the stool and tested by PCR directly after swabbing at 1 and 3 months after storage at -80°C. Stool and the liquid medium of FS were additionally tested by a combination of glutamate dehydrogenase antigen (GDH) testing and toxin A/B enzyme immunoassay (EIA), as well as by toxigenic culture (TC). Using dry swabs, the PCR-based detection rate of C. difficile was equal to the rate using stool samples (30/30 [100%]), whereas the detection rate in FS was significantly lower (25/30 [83.2%]; P = 0.019). The sensitivities of FS for detecting C. difficile by PCR, TC, GDH testing, and toxin A/B EIA were 83.3%, 85.7%, 88%, and 68.9%, respectively. Storage of swabs at -80°C had no impact on the detection rate. FS cannot replace stool samples in the two-step laboratory diagnosis of CDI, as the sensitivities were too low, probably due to diluting effects of the fecal sample in the liquid medium. For simple PCR-based detection of C. difficile, dry swabs proved to be a suitable alternative to the use of stool samples.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Clostridium difficile

Mesh:

Substances:

Year:  2018        PMID: 29720433      PMCID: PMC6018322          DOI: 10.1128/JCM.00426-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Comparison of the Copan ESwab system with two Amies agar swab transport systems for maintenance of microorganism viability.

Authors:  Kenneth G Van Horn; Carol D Audette; Denise Sebeck; Kelly A Tucker
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

2.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

3.  A novel use of rectal swab to test for Clostridium difficile infection by real-time PCR.

Authors:  Faiz A Shakir; David Thompson; Richard Marlar; Tauseef Ali
Journal:  Am J Gastroenterol       Date:  2012-09       Impact factor: 10.864

4.  Comparison of FecalSwab and ESwab devices for storage and transportation of Diarrheagenic bacteria.

Authors:  Jari J Hirvonen; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

5.  Comparison of Copan eSwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans.

Authors:  S Nys; S Vijgen; K Magerman; R Cartuyvels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-04       Impact factor: 3.267

6.  Reducing delays in the diagnosis and treatment of Clostridium difficile diarrhoea.

Authors:  M B Frenz; A S McIntyre
Journal:  QJM       Date:  2003-08

7.  Comparison of perirectal versus rectal swabs for detection of asymptomatic carriers of toxigenic Clostridium difficile.

Authors:  David S Rogers; Sirisha Kundrapu; Venkata C K Sunkesula; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

8.  Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.

Authors:  Yves Longtin; Bianka Paquet-Bolduc; Rodica Gilca; Christophe Garenc; Elise Fortin; Jean Longtin; Sylvie Trottier; Philippe Gervais; Jean-François Roussy; Simon Lévesque; Debby Ben-David; Isabelle Cloutier; Vivian G Loo
Journal:  JAMA Intern Med       Date:  2016-06-01       Impact factor: 21.873

9.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

10.  Evaluation of the New FecalSwab System for Maintaining Stability of Stool Samples Submitted for Molecular Tests.

Authors:  Suzane Silbert; Alicia Gostnell; Carly Kubasek; Raymond Widen
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

View more
  3 in total

1.  Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.

Authors:  Jay Worley; Mary L Delaney; Christopher K Cummins; Andrea DuBois; Michael Klompas; Lynn Bry
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital.

Authors:  Prameet M Sheth; Katya Douchant; Yvonne Uyanwune; Michael Larocque; Arravinth Anantharajah; Emily Borgundvaag; Lorraine Dales; Liz McCreight; Laura McNaught; Christine Moore; Kelsey Ragan; Allison McGeer; George Broukhanski
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

3.  Rectal Swabs as an Alternative Sample Collection Method to Bulk Stool for the Real-Time PCR Detection of Giardia duodenalis.

Authors:  Jacqueline R M A Maasch; Ahmed M Arzika; Catherine Cook; Elodie Lebas; Nils Pilotte; Jessica R Grant; Steven A Williams; Jeremy D Keenan; Thomas M Lietman; Kristen Aiemjoy
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.